BRCA1 and breast neoplasm: To date, two BRCA2 deficient tumours, two BRCA1 deficient tumours, and two BRCA1 deficient cell lines have also been subjected to medium-depth whole genome sequencing, as part of a wider study of primary breast tumours and cell lines [27].